肿瘤科

订阅

MedSci主页 / 所有栏目 / 肿瘤科

直播预告|“中西合璧 聚力前行”肿瘤综合治疗创新之路高峰论坛邀您参加！

2020-05-18 lingsun MedSci原创

关注

目前，新冠肺炎在全球蔓延，慢病诊疗面临患者救治和预防感染的双重压力，如何在疫情期间规范诊疗，同时做好患者管理是当前工作的重点和难点。在本次新冠疫情中，中医药发挥了重要作用，受到高度重视。

目前，新冠肺炎在全球蔓延，慢病诊疗面临患者救治和预防感染的双重压力，如何在疫情期间规范诊疗，同时做好患者管理是当前工作的重点和难点。在本次新冠疫情中，中医药发挥了重要作用，受到高度重视。事实上，在肿瘤的防治中，应用中西医综合治疗同样可以达到更好的治疗效果。如今，肿瘤中西医综合治疗越来越受到广大医生与患者的重视，众多临床学者开展了临床研究课题，将实验的重大成果更好的应用于临床，以提高肿瘤的诊疗水平、提高患者生活质量。

为促进广大医生交流，进一步探讨肿瘤综合治疗新途径，中华中医药学会络病学学分会主办，以岭药业承办的“中西医肿瘤综合治疗创新之路”高峰论坛将于5月20日19:00-20:30召开，届时将邀请中西医肿瘤领域各科专家在线解读肿瘤综合治疗进展以及临床应用探讨，全程网络直播，欢迎广大医生参加！

 

会议日程：

时间

内容

讲者

19:00-19:05

主席致辞

张明智教授

19:05-19:35

肺癌治疗病例分享

管 欣教授

病例解析 互动讨论

马学真教授、

杨晨光教授、解英教授

19:35-20:05

肝癌介入术后的综合治疗体会

孟艳莉教授

病例解析 互动讨论

王军教授、周晋华教授、

张莹雯教授

20:05-20:25

从注重生活质量与姑息治疗到中西医联合肿瘤综合治疗

邢力刚教授

20:25-20:30

互动&总结

张明智教授

 

 

识别二维码即可收看！欢迎围观！

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1662957, encodeId=7437166295e7d, content=<a href='/topic/show?id=0f1d102351f0' target=_blank style='color:#2F92EE;'>#高峰论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102351, encryptionId=0f1d102351f0, topicName=高峰论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad825519092, createdName=斯嘉莉, createdTime=Sat Nov 07 17:43:41 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1646881, encodeId=c4da16468811c, content=<a href='/topic/show?id=91cfe913977' target=_blank style='color:#2F92EE;'>#综合治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79139, encryptionId=91cfe913977, topicName=综合治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690523366225, createdName=zhaohui6739, createdTime=Tue May 26 19:43:41 CST 2020, time=2020-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285858, encodeId=da2812858586e, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed May 20 02:43:41 CST 2020, time=2020-05-20, status=1, ipAttribution=)]
    2020-11-07 斯嘉莉

    #高峰论坛#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1662957, encodeId=7437166295e7d, content=<a href='/topic/show?id=0f1d102351f0' target=_blank style='color:#2F92EE;'>#高峰论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102351, encryptionId=0f1d102351f0, topicName=高峰论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad825519092, createdName=斯嘉莉, createdTime=Sat Nov 07 17:43:41 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1646881, encodeId=c4da16468811c, content=<a href='/topic/show?id=91cfe913977' target=_blank style='color:#2F92EE;'>#综合治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79139, encryptionId=91cfe913977, topicName=综合治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690523366225, createdName=zhaohui6739, createdTime=Tue May 26 19:43:41 CST 2020, time=2020-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285858, encodeId=da2812858586e, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed May 20 02:43:41 CST 2020, time=2020-05-20, status=1, ipAttribution=)]
    2020-05-26 zhaohui6739

    #综合治疗#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1662957, encodeId=7437166295e7d, content=<a href='/topic/show?id=0f1d102351f0' target=_blank style='color:#2F92EE;'>#高峰论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102351, encryptionId=0f1d102351f0, topicName=高峰论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad825519092, createdName=斯嘉莉, createdTime=Sat Nov 07 17:43:41 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1646881, encodeId=c4da16468811c, content=<a href='/topic/show?id=91cfe913977' target=_blank style='color:#2F92EE;'>#综合治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79139, encryptionId=91cfe913977, topicName=综合治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=690523366225, createdName=zhaohui6739, createdTime=Tue May 26 19:43:41 CST 2020, time=2020-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285858, encodeId=da2812858586e, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed May 20 02:43:41 CST 2020, time=2020-05-20, status=1, ipAttribution=)]
    2020-05-20 lilianxiang

    #创新#

    0